Literature DB >> 17604539

Interval and clinical cohort studies: epidemiological issues.

Bryan Lau1, Stephen J Gange, Richard D Moore.   

Abstract

Cohort studies based upon clinic populations and medical records are becoming more abundant due in part to an increasing trend toward electronic medical records and advancement in information technology. This design has been utilized in the HIV setting to great success and involves following individuals as they access medical care. These clinical cohort designs have not been compared to the classic interval cohort design in which individuals are followed at specified intervals that are unrelated to the participants' ongoing health care. The interval and clinical cohort designs are distinguished and the advantages and disadvantages inherent in each design are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17604539     DOI: 10.1089/aid.2006.0171

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  36 in total

1.  A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa.

Authors:  Elvin H Geng; David V Glidden; David R Bangsberg; Mwebesa Bosco Bwana; Nicholas Musinguzi; Denis Nash; John Z Metcalfe; Constantin T Yiannoutsos; Jeffrey N Martin; Maya L Petersen
Journal:  Am J Epidemiol       Date:  2012-02-03       Impact factor: 4.897

2.  AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.

Authors:  Marlene Smurzynski; Ann C Collier; Susan L Koletar; Ronald J Bosch; Kunling Wu; Barbara Bastow; Constance A Benson
Journal:  HIV Clin Trials       Date:  2008 Jul-Aug

3.  Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001-2007.

Authors:  Chanelle J Howe; Stephen R Cole; Sonia Napravnik; Joseph J Eron
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08       Impact factor: 2.205

Review 4.  Identifying the appropriate comparison group for HIV-infected individuals.

Authors:  Cherise Wong; Keri Althoff; Stephen J Gange
Journal:  Curr Opin HIV AIDS       Date:  2014-07       Impact factor: 4.283

5.  Collaborative, pooled and harmonized study designs for epidemiologic research: challenges and opportunities.

Authors:  Catherine R Lesko; Lisa P Jacobson; Keri N Althoff; Alison G Abraham; Stephen J Gange; Richard D Moore; Sharada Modur; Bryan Lau
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

6.  Membranous Nephropathy: Quantifying Remission Duration on Outcome.

Authors:  Daniel C Cattran; Esther D Kim; Heather Reich; Michelle Hladunewich; S Joseph Kim
Journal:  J Am Soc Nephrol       Date:  2016-10-18       Impact factor: 10.121

7.  Retention among North American HIV-infected persons in clinical care, 2000-2008.

Authors:  Peter Rebeiro; Keri N Althoff; Kate Buchacz; John Gill; Michael Horberg; Hartmut Krentz; Richard Moore; Timothy R Sterling; John T Brooks; Kelly A Gebo; Robert Hogg; Marina Klein; Jeffrey Martin; Michael Mugavero; Sean Rourke; Michael J Silverberg; Jennifer Thorne; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731

8.  Laboratory Measures as Proxies for Primary Care Encounters: Implications for Quantifying Clinical Retention Among HIV-Infected Adults in North America.

Authors:  Peter F Rebeiro; Keri N Althoff; Bryan Lau; John Gill; Alison G Abraham; Michael A Horberg; Mari M Kitahata; Baligh R Yehia; Hasina Samji; John T Brooks; Kate Buchacz; Sonia Napravnik; Michael J Silverberg; Anita Rachlis; Kelly A Gebo; Timothy R Sterling; Richard D Moore; Stephen J Gange
Journal:  Am J Epidemiol       Date:  2015-11-17       Impact factor: 4.897

9.  Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death.

Authors:  Stephen R Cole; Lisa P Jacobson; Phyllis C Tien; Lawrence Kingsley; Joan S Chmiel; Kathryn Anastos
Journal:  Am J Epidemiol       Date:  2009-11-24       Impact factor: 4.897

10.  Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009.

Authors:  David B Hanna; Kate Buchacz; Kelly A Gebo; Nancy A Hessol; Michael A Horberg; Lisa P Jacobson; Gregory D Kirk; Mari M Kitahata; P Todd Korthuis; Richard D Moore; Sonia Napravnik; Pragna Patel; Michael J Silverberg; Timothy R Sterling; James H Willig; Bryan Lau; Keri N Althoff; Heidi M Crane; Ann C Collier; Hasina Samji; Jennifer E Thorne; M John Gill; Marina B Klein; Jeffrey N Martin; Benigno Rodriguez; Sean B Rourke; Stephen J Gange
Journal:  Clin Infect Dis       Date:  2013-01-11       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.